Loading...

EPS Holdings

OTCPK:EPLY.F
Snowflake Description

Flawless balance sheet second-rate dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EPLY.F
OTCPK
¥90B
Market Cap
  1. Home
  2. US
  3. Pharmaceuticals & Biotech
Company description

EPS Holdings, Inc. provides a range of contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development in Japan and rest of Asia. The last earnings update was 77 days ago. More info.


Add to Portfolio Compare Print
EPLY.F Share Price and Events
7 Day Returns
0%
OTCPK:EPLY.F
2.2%
US Life Sciences
1.2%
US Market
1 Year Returns
-
OTCPK:EPLY.F
26.9%
US Life Sciences
8.5%
US Market
EPLY.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
EPS Holdings (EPLY.F) 0% 0% - - 26% -
US Life Sciences 2.2% -0.9% 9.6% 26.9% 88.6% 120.6%
US Market 1.2% 3.8% 10% 8.5% 41.1% 47.2%
1 Year Return vs Industry and Market
  • No trading data on EPLY.F.
  • No trading data on EPLY.F.
Price Volatility
EPLY.F
Industry
5yr Volatility vs Market

EPLY.F Value

 Is EPS Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of EPS Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for EPS Holdings.

OTCPK:EPLY.F Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 2 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:EPLY.F
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Life Sciences Unlevered Beta Simply Wall St/ S&P Global 1.06
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.056 (1 + (1- 30.86%) (1.73%))
1.046
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.05
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.046 * 5.96%)
8.96%

Discounted Cash Flow Calculation for OTCPK:EPLY.F using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for EPS Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

OTCPK:EPLY.F DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (JPY, Millions) Source Present Value
Discounted (@ 8.96%)
2019 4,547.00 Analyst x1 4,172.98
2020 7,250.00 Analyst x2 6,106.34
2021 7,495.50 Analyst x2 5,793.82
2022 5,551.00 Analyst x1 3,937.83
2023 5,756.00 Analyst x1 3,747.38
2024 5,405.32 Est @ -6.09% 3,229.60
2025 5,219.06 Est @ -3.45% 2,861.82
2026 5,135.92 Est @ -1.59% 2,584.58
2027 5,120.72 Est @ -0.3% 2,364.95
2028 5,152.04 Est @ 0.61% 2,183.70
Present value of next 10 years cash flows ¥36,982.99
OTCPK:EPLY.F DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= ¥5,152.04 × (1 + 2.73%) ÷ (8.96% – 2.73%)
¥84,915.38
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ¥84,915.38 ÷ (1 + 8.96%)10
¥35,991.49
OTCPK:EPLY.F Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ¥36,982.99 + ¥35,991.49
¥72,974.48
Equity Value per Share
(JPY)
= Total value / Shares Outstanding
= ¥72,974.48 / 45.36
¥1608.85
OTCPK:EPLY.F Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in OTCPK:EPLY.F represents 0.00789x of TSE:4282
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.00789x
Value per Share
(Listing Adjusted, USD)
= Value per Share (JPY) x Listing Adjustment Factor
= ¥ 1,608.85 x 0.00789
$12.69
Value per share (USD) From above. $12.69
Current discount Discount to share price of $15.66
= -1 x ($15.66 - $12.69) / $12.69
-23.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of EPS Holdings is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for EPS Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are EPS Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:EPLY.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in JPY ¥94.08
TSE:4282 Share Price ** TSE (2019-02-01) in JPY ¥1985
United States of America Life Sciences Industry PE Ratio Median Figure of 21 Publicly-Listed Life Sciences Companies 34.56x
United States of America Market PE Ratio Median Figure of 3,075 Publicly-Listed Companies 18.19x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of EPS Holdings.

OTCPK:EPLY.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSE:4282 Share Price ÷ EPS (both in JPY)

= 1985 ÷ 94.08

21.1x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EPS Holdings is good value based on earnings compared to the US Life Sciences industry average.
  • EPS Holdings is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does EPS Holdings's expected growth come at a high price?
Raw Data
OTCPK:EPLY.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 21.1x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
7.8%per year
United States of America Life Sciences Industry PEG Ratio Median Figure of 19 Publicly-Listed Life Sciences Companies 2.79x
United States of America Market PEG Ratio Median Figure of 2,108 Publicly-Listed Companies 1.61x

*Line of best fit is calculated by linear regression .

OTCPK:EPLY.F PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 21.1x ÷ 7.8%

2.71x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EPS Holdings is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on EPS Holdings's assets?
Raw Data
OTCPK:EPLY.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in JPY ¥973.54
TSE:4282 Share Price * TSE (2019-02-01) in JPY ¥1985
United States of America Life Sciences Industry PB Ratio Median Figure of 39 Publicly-Listed Life Sciences Companies 4.89x
United States of America Market PB Ratio Median Figure of 5,185 Publicly-Listed Companies 1.92x
OTCPK:EPLY.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSE:4282 Share Price ÷ Book Value per Share (both in JPY)

= 1985 ÷ 973.54

2.04x

* Primary Listing of EPS Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • EPS Holdings is good value based on assets compared to the US Life Sciences industry average.
X
Value checks
We assess EPS Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Life Sciences industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Life Sciences industry average (and greater than 0)? (1 check)
  5. EPS Holdings has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

EPLY.F Future Performance

 How is EPS Holdings expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
7.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is EPS Holdings expected to grow at an attractive rate?
  • EPS Holdings's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • EPS Holdings's earnings growth is positive but not above the United States of America market average.
  • EPS Holdings's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
OTCPK:EPLY.F Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:EPLY.F Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 7.8%
OTCPK:EPLY.F Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 6.8%
United States of America Life Sciences Industry Earnings Growth Rate Market Cap Weighted Average 15%
United States of America Life Sciences Industry Revenue Growth Rate Market Cap Weighted Average 7%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.1%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:EPLY.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in JPY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:EPLY.F Future Estimates Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-09-30
2022-09-30
2021-09-30 81,000 6,231 5,440 2
2020-09-30 76,600 6,001 5,090 2
2019-09-30 72,250 5,497 4,775 2
OTCPK:EPLY.F Past Financials Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income *
2018-12-31 66,167 4,300
2018-09-30 65,769 3,465 4,388
2018-06-30 64,307 4,581
2018-03-31 62,751 6,480 4,603
2017-12-31 61,735 5,047
2017-09-30 60,482 7,835 4,663
2017-06-30 59,153 4,337
2017-03-31 57,450 5,484 3,997
2016-12-31 55,666 3,737
2016-09-30 52,703 5,186 3,966
2016-06-30 50,737 3,747
2016-03-31 48,800 6,100 3,703

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • EPS Holdings's earnings are expected to grow by 7.8% yearly, however this is not considered high growth (20% yearly).
  • EPS Holdings's revenue is expected to grow by 6.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:EPLY.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from EPS Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:EPLY.F Future Estimates Data
Date (Data in JPY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-09-30
2022-09-30
2021-09-30 119.30 132.30 106.30 2.00
2020-09-30 111.60 119.10 104.10 2.00
2019-09-30 104.65 106.90 102.40 2.00
OTCPK:EPLY.F Past Financials Data
Date (Data in JPY Millions) EPS *
2018-12-31 94.08
2018-09-30 95.66
2018-06-30 99.45
2018-03-31 99.79
2017-12-31 109.46
2017-09-30 101.15
2017-06-30 94.86
2017-03-31 88.16
2016-12-31 82.98
2016-09-30 92.31
2016-06-30 90.81
2016-03-31 93.60

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • EPS Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess EPS Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
EPS Holdings has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

EPLY.F Past Performance

  How has EPS Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare EPS Holdings's growth in the last year to its industry (Life Sciences).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • EPS Holdings has delivered over 20% year on year earnings growth in the past 5 years.
  • EPS Holdings's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • EPS Holdings's 1-year earnings growth is negative, it can't be compared to the US Life Sciences industry average.
Earnings and Revenue History
EPS Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from EPS Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:EPLY.F Past Revenue, Cash Flow and Net Income Data
Date (Data in JPY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 66,167.00 4,300.00 16,706.00
2018-09-30 65,769.00 4,388.00 16,106.00
2018-06-30 64,307.00 4,581.00 14,967.00
2018-03-31 62,751.00 4,603.00 13,701.00
2017-12-31 61,735.00 5,047.00 12,668.00
2017-09-30 60,482.00 4,663.00 11,484.00
2017-06-30 59,153.00 4,337.00 10,819.00
2017-03-31 57,450.00 3,997.00 10,403.00
2016-12-31 55,666.00 3,737.00 10,207.00
2016-09-30 52,703.00 3,966.00 9,398.00
2016-06-30 50,737.00 3,747.00 9,218.00
2016-03-31 48,800.00 3,703.00 8,721.00
2015-12-31 46,239.00 2,902.00 8,253.00
2015-09-30 45,202.00 2,163.00 8,282.00
2015-06-30 44,264.00 2,226.00 8,154.00
2015-03-31 44,000.00 1,916.00 8,321.00
2014-12-31 43,284.00 2,091.00 8,061.00
2014-09-30 41,800.00 1,828.00 8,010.00
2014-06-30 41,049.00 2,495.00 7,465.00
2014-03-31 39,199.00 1,934.00 7,067.00
2013-12-31 38,057.00 1,498.00 6,926.00
2013-09-30 37,584.00 1,709.00 6,688.00
2013-06-30 36,296.00 948.00 6,596.00
2013-03-31 36,097.00 1,696.00 6,558.00
2012-12-31 35,556.00 1,968.00 6,480.00
2012-09-30 35,202.00 2,207.00 6,476.00
2012-06-30 34,449.00 2,577.00 6,330.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • EPS Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • EPS Holdings used its assets less efficiently than the US Life Sciences industry average last year based on Return on Assets.
  • EPS Holdings's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess EPS Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Life Sciences industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
EPS Holdings has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

EPLY.F Health

 How is EPS Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up EPS Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • EPS Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • EPS Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of EPS Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 25.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from EPS Holdings Company Filings, last reported 3 months ago.

OTCPK:EPLY.F Past Debt and Equity Data
Date (Data in JPY Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 47,383.00 1,555.00 18,566.00
2018-09-30 46,743.00 1,585.00 19,214.00
2018-06-30 46,255.00 1,918.00 20,040.00
2018-03-31 46,751.00 2,112.00 21,891.00
2017-12-31 45,651.00 2,305.00 19,394.00
2017-09-30 44,860.00 2,499.00 23,435.00
2017-06-30 43,310.00 2,942.00 20,389.00
2017-03-31 42,444.00 3,135.00 20,172.00
2016-12-31 41,071.00 3,590.00 17,365.00
2016-09-30 34,364.00 3,583.00 16,626.00
2016-06-30 34,007.00 4,930.00 17,116.00
2016-03-31 34,369.00 5,468.00 17,451.00
2015-12-31 24,363.00 5,521.00 13,597.00
2015-09-30 23,588.00 4,497.00 14,730.00
2015-06-30 22,887.00 5,686.00 14,167.00
2015-03-31 22,378.00 4,677.00 12,165.00
2014-12-31 21,892.00 3,794.00 10,339.00
2014-09-30 21,229.00 3,905.00 11,747.00
2014-06-30 20,088.00 4,054.00 10,474.00
2014-03-31 20,388.00 4,965.00 11,774.00
2013-12-31 19,734.00 4,159.00 11,120.00
2013-09-30 20,060.00 3,470.00 10,474.00
2013-06-30 18,818.00 2,030.00 9,173.00
2013-03-31 19,063.00 1,780.00 9,326.00
2012-12-31 18,300.00 2,280.00 9,858.00
2012-09-30 18,436.00 915.00 10,576.00
2012-06-30 17,862.00 933.00 9,563.00
  • EPS Holdings's level of debt (3.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (21.1% vs 3.3% today).
  • Debt is well covered by operating cash flow (222.8%, greater than 20% of total debt).
  • EPS Holdings earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess EPS Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. EPS Holdings has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

EPLY.F Dividends

 What is EPS Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.41%
Current annual income from EPS Holdings dividends. Estimated to be 1.52% next year.
If you bought $2,000 of EPS Holdings shares you are expected to receive $28 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • EPS Holdings's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.41%).
  • EPS Holdings's dividend is below the markets top 25% of dividend payers in United States of America (3.62%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:EPLY.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
United States of America Life Sciences Industry Average Dividend Yield Market Cap Weighted Average of 7 Stocks 0.4%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2004 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:EPLY.F Future Dividends Estimate Data
Date (Data in ¥) Dividend per Share (annual) Avg. No. Analysts
2023-09-30
2022-09-30
2021-09-30 32.50 2.00
2020-09-30 30.00 2.00
2019-09-30 28.00 2.00
OTCPK:EPLY.F Past Annualized Dividends Data
Date (Data in ¥) Dividend per share (annual) Avg. Yield (%)
2018-12-21 28.000 1.546
2018-11-07 28.000 1.410
2018-08-13 26.000 1.152
2018-08-01 26.000 1.165
2018-05-14 26.000 1.167
2018-05-01 26.000 1.233
2017-12-22 32.000 1.366
2017-11-07 25.000 1.063
2017-08-14 24.000 1.125
2017-08-01 24.000 1.172
2017-05-12 24.000 1.379
2017-05-02 24.000 1.448
2016-12-22 22.000 1.486
2016-11-08 22.000 1.630
2016-02-01 18.000 1.321
2015-12-22 18.000 1.419
2015-11-06 18.000 1.330
2014-12-19 18.000 1.273
2014-11-06 18.000 1.508
2014-08-01 18.000 1.351
2014-05-01 18.000 1.435
2013-12-20 18.000 1.586
2013-11-07 18.000 1.575
2013-08-01 18.000 1.884
2013-05-01 18.000 1.445
2013-02-01 18.000 1.371
2012-12-21 17.500 1.466
2012-11-06 18.000 1.593
2012-08-01 17.500 1.551
2012-05-01 17.500 1.731
2012-02-01 17.500 1.979
2011-12-22 17.500 2.451
2011-11-07 17.500 2.252
2011-07-29 17.500 1.991
2011-01-31 17.500 1.920
2010-12-22 17.500 1.782
2010-11-05 17.500 1.866
2010-07-30 16.500 1.575
2010-04-30 16.500 1.480
2010-01-29 16.500 1.615
2009-12-18 16.500 1.871
2009-11-06 16.500 1.897
2009-08-13 15.000 1.630
2009-07-31 15.000 1.528

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of EPS Holdings's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.8x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess EPS Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can EPS Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. EPS Holdings has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

EPLY.F Management

 What is the CEO of EPS Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Hisashi Tanaka
AGE 63
TENURE AS CEO 0.3 years
CEO Bio

Mr. Hisashi Tanaka has been the President of EPS Holdings, Inc. since December 2018 and serves as its Representative Corporate Officer. Mr. Tanaka served as an Executive Vice President of EPS Holdings, Inc. since December 22, 2015 until December 2018. Mr. Tanaka serves as the President of EPS Corporation. He served as Chief Executive Officer and President at EPS Associates Co., Ltd. He served as Managing Officer and General Manager of CRO Business Division at EPS Holdings, Inc. since October 21, 2013. He serves as the Chairman of EPS International Holdings Co., Ltd. He has been a Representative Director of EPS Holdings, Inc. since October 21, 2013. He serves as Representative Director of EPS International Holdings Co., Ltd. and EPS Corporation.

CEO Compensation
  • Insufficient data for Hisashi to compare compensation growth.
  • Insufficient data for Hisashi to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the EPS Holdings management team in years:

0.3
Average Tenure
61.5
Average Age
  • The average tenure for the EPS Holdings management team is less than 2 years, this suggests a new team.
Management Team

Yan Hao

TITLE
Chairman of the Board & Representative Corporate Officer
AGE
56

Hisashi Tanaka

TITLE
President
AGE
63
TENURE
0.3 yrs

Haruo Nishino

TITLE
Vice-Chairman of the Board & Corporate Officer
AGE
68

Yasuharu Tamai

TITLE
Senior Corporate Officer
AGE
57
TENURE
0.3 yrs

Hidetaka Ando

TITLE
Senior Corporate Officer
AGE
58
TENURE
0.3 yrs

Shuzo Orihashi

TITLE
Managing Corporate Officer & Director
AGE
60

Shinro Tashiro

TITLE
Vice Chairman
AGE
63

Kazuki Sekitani

TITLE
Managing Corporate Officer & Director

Junichi Nishizuka

TITLE
Senior Corporate Officer
TENURE
0.3 yrs

Hiroaki Abe

TITLE
Corporate Officer
AGE
64
Board of Directors Tenure

Average tenure and age of the EPS Holdings board of directors in years:

4.3
Average Tenure
63
Average Age
  • The tenure for the EPS Holdings board of directors is about average.
Board of Directors

Yan Hao

TITLE
Chairman of the Board & Representative Corporate Officer
AGE
56

Hisashi Tanaka

TITLE
President
AGE
63

Haruo Nishino

TITLE
Vice-Chairman of the Board & Corporate Officer
AGE
68
TENURE
3.3 yrs

Shuzo Orihashi

TITLE
Managing Corporate Officer & Director
AGE
60

Shinro Tashiro

TITLE
Vice Chairman
AGE
63

Kazuki Sekitani

TITLE
Managing Corporate Officer & Director

Yoshinori Ando

TITLE
External Director
AGE
61
TENURE
7.3 yrs

Tomohiro Tominaga

TITLE
Standing Corporate Auditor
AGE
71
TENURE
3.3 yrs

Haruo Funabashi

TITLE
External Auditor
AGE
72
TENURE
7.3 yrs

Junichiro Tsuji

TITLE
External Auditor
AGE
76
TENURE
4.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess EPS Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. EPS Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

EPLY.F News

Simply Wall St News

EPLY.F Company Info

Description

EPS Holdings, Inc. provides a range of contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development in Japan and rest of Asia. It is also involved in the planning and implementation of clinical studies to applications and post-marketing surveillance; and provision of optimized services for the development of pharmaceuticals and medical devices. In addition, the company provides support services for the implementation of clinical trials and studies in a range of fields; a range of services, such as contract medical representative and call center operation to pharmaceutical and healthcare companies; and planning, implementation, data processing/management, statistical analysis, and medical/research paper drafting services for clinical researches. Further, it researches and develops, manufactures, and sells pharmaceuticals and medical devices, as well as provides other specialized services. The company serves pharmaceutical companies, medical device manufacturers, and medical institutions. EPS Holdings, Inc. was founded in 1991 and is based in Tokyo, Japan.

Details
Name: EPS Holdings, Inc.
EPLY.F
Exchange: OTCPK
Founded: 1991
¥805,331,829
45,358,236
Website: http://www.eps-holdings.co.jp
Address: EPS Holdings, Inc.
Kagurazaka AK Building,
6th Floor,
Tokyo,
162-0821,
Japan
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSE 4282 Common Stock The Tokyo Stock Exchange JP JPY 09. Jul 2001
OTCPK EPLY.F Common Stock Pink Sheets LLC US USD 09. Jul 2001
Number of employees
Current staff
Staff numbers
5,695
EPS Holdings employees.
Industry
Life Sciences Tools and Services
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/30 00:18
End of day share price update: 2019/02/01 00:00
Last estimates confirmation: 2019/02/04
Last earnings filing: 2019/02/12
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/09/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.